- Home
- HIO vs VSTM Comparison
HIO vs VSTM Comparison
Compare HIO & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIO
- VSTM
- Stock Information
- Founded
- HIO 1993
- VSTM 2010
- Country
- HIO United States
- VSTM United States
- Employees
- HIO N/A
- VSTM N/A
- Industry
- HIO Finance/Investors Services
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- HIO Finance
- VSTM Health Care
- Exchange
- HIO Nasdaq
- VSTM Nasdaq
- Market Cap
- HIO 366.1M
- VSTM 425.9M
- IPO Year
- HIO N/A
- VSTM 2012
- Fundamental
- Price
- HIO $3.89
- VSTM $6.02
- Analyst Decision
- HIO
- VSTM Strong Buy
- Analyst Count
- HIO 0
- VSTM 9
- Target Price
- HIO N/A
- VSTM $13.63
- AVG Volume (30 Days)
- HIO 305.3K
- VSTM 2.6M
- Earning Date
- HIO 01-01-0001
- VSTM 05-13-2025
- Dividend Yield
- HIO 10.33%
- VSTM N/A
- EPS Growth
- HIO N/A
- VSTM N/A
- EPS
- HIO N/A
- VSTM N/A
- Revenue
- HIO N/A
- VSTM $10,000,000.00
- Revenue This Year
- HIO N/A
- VSTM $106.87
- Revenue Next Year
- HIO N/A
- VSTM $312.95
- P/E Ratio
- HIO N/A
- VSTM N/A
- Revenue Growth
- HIO N/A
- VSTM N/A
- 52 Week Low
- HIO $3.52
- VSTM $2.10
- 52 Week High
- HIO $4.03
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- HIO 56.83
- VSTM 38.94
- Support Level
- HIO $3.79
- VSTM $7.60
- Resistance Level
- HIO $3.92
- VSTM $9.10
- Average True Range (ATR)
- HIO 0.04
- VSTM 0.90
- MACD
- HIO 0.00
- VSTM -0.16
- Stochastic Oscillator
- HIO 76.92
- VSTM 6.67
About HIO Western Asset High Income Opportunity Fund Inc.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.